Related Experiment Video
Updated: Jun 20, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis
Camino Bermejo-Rodriguez1, Joaquín Araos Henríquez2, Giuseppina Caligiuri3,4
1Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Scribble (SCRIB) loss promotes invasive pancreatic ductal adenocarcinoma (PDAC) by enhancing cancer cell survival and altering the tumor microenvironment. Reduced SCRIB expression correlates with poorer patient outcomes, suggesting its tumor suppressor role in advanced PDAC.
Area of Science:
- Oncology
- Cell Biology
- Cancer Pathogenesis
Background:
- Cell polarity disruption is a key feature of pancreatic ductal adenocarcinoma (PDAC) progression.
- Scribble (SCRIB), a polarity regulator, has varied roles in neoplasm pathogenesis.
Purpose of the Study:
- To investigate the role of SCRIB deficiency in PDAC development and progression.
- To determine the impact of Scrib ablation on tumor initiation, invasion, and metastasis in mouse models.
Main Methods:
- Genetic ablation of Scrib expression in established mouse models of PDAC.
- Immunohistochemical and transcriptome analyses of Scrib-null tumors.
- In vitro studies using mouse PDAC organoids (mPDOs) and PDAC cell lines.
Main Results:
- Scrib deletion cooperated with KrasG12D and Trp53 heterozygous deletion to promote invasive PDAC and metastasis.
- Scrib-null tumors showed reduced collagen, increased cancer-associated fibroblasts (CAFs), and decreased IL1α levels.
- Scrib loss enhanced YAP activation, increasing cancer cell survival and impairing CAF activation.
Conclusions:
- SCRIB deficiency accelerates PDAC development and progression through both cell-autonomous and non-cell-autonomous mechanisms.
- Reduced SCRIB expression in human PDAC is linked to poorer patient outcomes.
- SCRIB functions as a tumor suppressor in advanced pancreatic cancer and may serve as a biomarker for recurrence prediction.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Insulin Secretory Vesicles

